To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05868395
Title Efficacy of Polatuzumab, Bendamustine and Rituximab in Patients With Relapsed/ Refractory Mantle Cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Medical University of Vienna
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUT

Facility Status City State Zip Country Details
AKH Vienna, Division of Oncology Department of Medicine I RECRUITING Vienna 1090 Austria Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field